SUVRETTA CAPITAL MANAGEMENT, LLC - Q4 2022 holdings

$2.38 Billion is the total value of SUVRETTA CAPITAL MANAGEMENT, LLC's 89 reported holdings in Q4 2022. The portfolio turnover from Q3 2022 to Q4 2022 was 90.4% .

 Value Shares↓ Weighting
UNH BuyUNITEDHEALTH GROUP INC$136,104,629
+11.8%
256,714
+6.5%
5.72%
+13.1%
UNP SellUNION PAC CORP$107,919,293
+3.9%
521,173
-2.2%
4.53%
+5.1%
OTIS  OTIS WORLDWIDE CORP$101,605,659
+22.7%
1,297,4800.0%4.27%
+24.2%
HZNP BuyHORIZON THERAPEUTICS PUB L$99,494,316
+125.6%
874,291
+22.7%
4.18%
+128.2%
EL BuyLAUDER ESTEE COS INCcl a$98,873,324
+23.9%
398,506
+7.8%
4.15%
+25.4%
TPR  TAPESTRY INC$83,049,510
+33.9%
2,180,9220.0%3.49%
+35.5%
KURA BuyKURA ONCOLOGY INC$79,136,274
+42.6%
6,376,815
+56.9%
3.32%
+44.2%
LVS SellLAS VEGAS SANDS CORP$78,146,678
-13.0%
1,625,685
-32.1%
3.28%
-12.0%
RPRX BuyROYALTY PHARMA PLC$78,037,180
+5.4%
1,974,625
+7.2%
3.28%
+6.6%
BuyARCELLX INC$72,813,316
+72.4%
2,350,333
+4.5%
3.06%
+74.4%
NKE NewNIKE INCcl b$58,263,608497,937
+100.0%
2.45%
CP SellCANADIAN PAC RY LTD$57,124,006
+10.3%
765,840
-1.3%
2.40%
+11.5%
WYNN NewWYNN RESORTS LTD$56,492,032685,001
+100.0%
2.37%
HLT SellHILTON WORLDWIDE HLDGS INC$55,188,488
-16.1%
436,756
-19.9%
2.32%
-15.1%
ITCI BuyINTRA-CELLULAR THERAPIES INC$54,875,288
+38.4%
1,036,948
+21.7%
2.30%
+40.0%
T NewAT&T INC$54,344,4792,951,900
+100.0%
2.28%
BuyBIOHAVEN LTD$53,423,259
+13668.9%
3,848,938
+6145.1%
2.24%
+13925.0%
SQ BuyBLOCK INCcl a$53,056,001
+45.8%
844,303
+27.6%
2.23%
+47.5%
CL NewCOLGATE PALMOLIVE CO$50,786,458644,580
+100.0%
2.13%
INSM BuyINSMED INC$50,367,602
+90.0%
2,520,901
+104.8%
2.12%
+92.2%
SCHW NewSCHWAB CHARLES CORP$50,306,025604,204
+100.0%
2.11%
FIS NewFIDELITY NATL INFORMATION SV$47,020,389693,005
+100.0%
1.98%
STRO BuySUTRO BIOPHARMA INC$44,966,000
+61.4%
5,565,099
+10.9%
1.89%
+63.3%
SBUX NewSTARBUCKS CORP$44,445,667448,041
+100.0%
1.87%
DG NewDOLLAR GEN CORP NEW$42,810,563173,850
+100.0%
1.80%
RARE BuyULTRAGENYX PHARMACEUTICAL IN$37,859,532
+928.0%
817,171
+818.8%
1.59%
+939.2%
KDNY BuyCHINOOK THERAPEUTICS INC$37,854,546
+38.5%
1,444,830
+3.9%
1.59%
+40.1%
NewCONSTELLATION ENERGY CORP$37,240,047431,969
+100.0%
1.56%
TERN NewTERNS PHARMACEUTICALS INC$35,103,4403,448,275
+100.0%
1.47%
AMD NewADVANCED MICRO DEVICES INC$31,332,876483,756
+100.0%
1.32%
FULC BuyFULCRUM THERAPEUTICS INC$31,120,566
+9.0%
4,274,803
+21.2%
1.31%
+10.3%
XLE NewSELECT SECTOR SPDR TRenergy$29,964,598342,570
+100.0%
1.26%
FB SellMETA PLATFORMS INCcl a$29,634,808
-56.2%
246,259
-50.6%
1.24%
-55.6%
ORCL NewORACLE CORP$29,288,505358,313
+100.0%
1.23%
KZR BuyKEZAR LIFE SCIENCES INC$24,670,019
-12.5%
3,504,264
+7.0%
1.04%
-11.5%
GFL  GFL ENVIRONMENTAL INC$22,034,100
+15.6%
753,8180.0%0.92%
+16.8%
 PROKIDNEY CORP$21,905,181
-23.9%
3,193,1750.0%0.92%
-23.0%
MCK SellMCKESSON CORP$21,797,473
-38.8%
58,108
-44.6%
0.92%
-38.1%
COGT SellCOGENT BIOSCIENCES INC$20,939,738
-24.7%
1,811,396
-2.7%
0.88%
-23.8%
ABC SellAMERISOURCEBERGEN CORP$20,657,077
-55.3%
124,658
-63.5%
0.87%
-54.8%
AGIO SellAGIOS PHARMACEUTICALS INC$19,256,478
-29.0%
685,772
-28.5%
0.81%
-28.2%
BuyMARINUS PHARMACEUTICALS INC$19,195,520
-18.4%
4,822,995
+36.3%
0.81%
-17.5%
PNT BuyPOINT BIOPHARMA GLOBAL INC$19,150,830
+6.3%
2,627,000
+12.7%
0.80%
+7.5%
DFS NewDISCOVER FINL SVCS$16,318,924166,809
+100.0%
0.68%
ANTM NewELEVANCE HEALTH INC$14,861,25428,971
+100.0%
0.62%
NVDA NewNVIDIA CORPORATION$12,766,49887,358
+100.0%
0.54%
PRTA SellPROTHENA CORP PLC$12,438,492
-35.2%
206,448
-34.8%
0.52%
-34.5%
ROST NewROSS STORES INC$12,191,993105,040
+100.0%
0.51%
EYPT BuyEYEPOINT PHARMACEUTICALS INC$11,717,640
-54.2%
3,347,897
+3.5%
0.49%
-53.7%
ORIC  ORIC PHARMACEUTICALS INC$11,206,567
+84.1%
1,902,6430.0%0.47%
+86.2%
SellPEPGEN INC$11,071,523
+3.3%
828,087
-29.9%
0.46%
+4.5%
 ALVOTECHordinary shares$10,000,000
+47.9%
1,000,0000.0%0.42%
+49.5%
KALV SellKALVISTA PHARMACEUTICALS INC$7,248,762
-70.7%
1,072,302
-37.2%
0.30%
-70.5%
IFRX  INFLARX NV$6,653,344
+17.4%
2,146,2400.0%0.28%
+18.7%
 VENTYX BIOSCIENCES INC$6,112,056
-6.1%
186,4000.0%0.26%
-4.8%
MREO  MEREO BIOPHARMA GROUP PLCspon ads$5,523,329
-12.9%
7,364,4380.0%0.23%
-11.8%
JNJ NewJOHNSON & JOHNSON$5,174,07929,290
+100.0%
0.22%
BNTX NewBIONTECH SEsponsored ads$4,596,73230,600
+100.0%
0.19%
ATAI BuyATAI LIFE SCIENCES NV$4,356,974
+7.4%
1,637,960
+33.7%
0.18%
+8.9%
ELAN NewELANCO ANIMAL HEALTH INC$4,330,768354,400
+100.0%
0.18%
 AKILI INC$4,059,063
-50.4%
3,624,1630.0%0.17%
-50.0%
MOLN  MOLECULAR PARTNERS AGads$2,620,000
-2.1%
400,0000.0%0.11%
-0.9%
NTRA NewNATERA INC$2,084,82351,900
+100.0%
0.09%
GLPG NewGALAPAGOS NVspon adr$2,094,73647,200
+100.0%
0.09%
DHR SellDANAHER CORPORATION$1,972,601
-96.6%
7,432
-96.7%
0.08%
-96.6%
TMO SellTHERMO FISHER SCIENTIFIC INC$1,850,318
-96.8%
3,360
-97.1%
0.08%
-96.8%
AGLE  AEGLEA BIOTHERAPEUTICS INC$1,826,546
-14.5%
4,059,8940.0%0.08%
-13.5%
ABT NewABBOTT LABS$1,131,93510,310
+100.0%
0.05%
SNY NewSANOFIsponsored adr$1,095,00222,610
+100.0%
0.05%
AZN NewASTRAZENECA PLCsponsored adr$1,063,78215,690
+100.0%
0.04%
MDT NewMEDTRONIC PLC$727,9269,366
+100.0%
0.03%
BSX NewBOSTON SCIENTIFIC CORP$654,30414,141
+100.0%
0.03%
IQV SellIQVIA HLDGS INC$606,270
-99.1%
2,959
-99.2%
0.02%
-99.1%
ARGX NewARGENX SEsponsored adr$575,8221,520
+100.0%
0.02%
ILMN NewILLUMINA INC$568,1822,810
+100.0%
0.02%
BIIB NewBIOGEN INC$395,9961,430
+100.0%
0.02%
ISRG NewINTUITIVE SURGICAL INC$411,2931,550
+100.0%
0.02%
SYK NewSTRYKER CORPORATION$405,8531,660
+100.0%
0.02%
IDXX NewIDEXX LABS INC$375,323920
+100.0%
0.02%
WAT NewWATERS CORP$325,451950
+100.0%
0.01%
BMRN NewBIOMARIN PHARMACEUTICAL INC$276,3182,670
+100.0%
0.01%
CVS NewCVS HEALTH CORP$267,4552,870
+100.0%
0.01%
BMY NewBRISTOL-MYERS SQUIBB CO$235,9963,280
+100.0%
0.01%
MTD NewMETTLER TOLEDO INTERNATIONAL$237,054164
+100.0%
0.01%
GMAB NewGENMAB A/Ssponsored ads$220,8005,210
+100.0%
0.01%
TECH NewBIO-TECHNE CORP$215,4882,600
+100.0%
0.01%
CRL NewCHARLES RIV LABS INTL INC$220,0791,010
+100.0%
0.01%
BNTC  BENITEC BIOPHARMA INC$130,730
-54.3%
769,0000.0%0.01%
-58.3%
 OPY ACQUISITION CORP I*w exp 09/22/202$3,645
-54.4%
72,6050.0%0.00%
TMPMW ExitTURMERIC ACQUISITION CORP*w exp 10/08/202$0-52,775
-100.0%
0.00%
FLAC ExitFRAZIER LIFESCIENCES ACQU CO$0-87,498
-100.0%
-0.04%
OTIC ExitOTONOMY INC$0-3,144,196
-100.0%
-0.04%
AMAM ExitAMBRX BIOPHARMA INCsponsored ads$0-1,491,832
-100.0%
-0.07%
SIOX ExitSIO GENE THERAPIES INC$0-5,914,000
-100.0%
-0.07%
ExitNUVALENT INC$0-101,003
-100.0%
-0.08%
ExitTHIRD HARMONIC BIO INC$0-200,000
-100.0%
-0.16%
GMTX ExitGEMINI THERAPEUTICS INC$0-2,372,267
-100.0%
-0.16%
BOLT ExitBOLT BIOTHERAPEUTICS INC$0-2,672,000
-100.0%
-0.16%
SLDB ExitSOLID BIOSCIENCES INC$0-600,000
-100.0%
-0.17%
PHVS ExitPHARVARIS N V$0-746,965
-100.0%
-0.24%
LEGN ExitLEGEND BIOTECH CORPsponsored ads$0-274,200
-100.0%
-0.46%
LLY ExitLILLY ELI & CO$0-35,200
-100.0%
-0.47%
HRTX ExitHERON THERAPEUTICS INC$0-2,807,000
-100.0%
-0.49%
MAR ExitMARRIOTT INTL INC NEWcl a$0-134,800
-100.0%
-0.78%
LVS ExitLAS VEGAS SANDS CORPcall$0-890,000
-100.0%
-1.39%
V ExitVISA INC$0-271,968
-100.0%
-2.01%
TMUS ExitT-MOBILE US INC$0-369,828
-100.0%
-2.06%
MA ExitMASTERCARD INCORPORATEDcl a$0-181,691
-100.0%
-2.14%
NOW ExitSERVICENOW INC$0-154,150
-100.0%
-2.42%
TTWO ExitTAKE-TWO INTERACTIVE SOFTWAR$0-536,170
-100.0%
-2.43%
GPN ExitGLOBAL PMTS INC$0-658,992
-100.0%
-2.96%
AMZN ExitAMAZON COM INC$0-733,460
-100.0%
-3.44%
DIS ExitDISNEY WALT CO$0-926,850
-100.0%
-3.63%
MSFT ExitMICROSOFT CORP$0-382,380
-100.0%
-3.70%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2023-02-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
ADOBE SYSTEMS INCORPORATED33Q4 202113.2%
CONSTELLATION BRANDS INC20Q4 201810.9%
AMAZON COM INC20Q3 20238.0%
UNITEDHEALTH GROUP INC20Q3 20235.7%
IQVIA HLDGS INC19Q3 20237.3%
RESTAURANT BRANDS INTL INC18Q3 20198.9%
UNION PAC CORP17Q2 20235.1%
META PLATFORMS INC16Q3 202310.9%
COPART INC15Q4 20212.3%
SUTRO BIOPHARMA INC15Q3 20231.9%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
SUVRETTA CAPITAL MANAGEMENT, LLC Q4 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Zura Bio LtdJune 15, 20232,850,0006.6%
InflaRx N.V.April 24, 20235,733,91010.3%
Benitec Biopharma Inc.April 18, 20233,020,21410.0%
Aeglea BioTherapeutics, Inc.February 13, 20236,376,37310.0%
Bolt Biotherapeutics, Inc.Sold outFebruary 13, 202300.0%
Cano Health, Inc.Sold outFebruary 13, 202300.0%
CHIMERIX INCSold outFebruary 13, 202300.0%
Disc Medicine, Inc.Sold outFebruary 13, 202300.0%
OTONOMY, INC.Sold outFebruary 13, 202300.0%
Sio Gene Therapies Inc.Sold outFebruary 13, 202300.0%

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete significant-ownership history.

Latest filings
TypeFiled
SC 13G2024-04-15
13F-HR2024-02-14
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13
SC 13G/A2024-02-13

View SUVRETTA CAPITAL MANAGEMENT, LLC's complete filings history.

Compare quarters

Export SUVRETTA CAPITAL MANAGEMENT, LLC's holdings